{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:49:27Z","timestamp":1775198967855,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Unknown factors contribute to psoriasis' hyperproliferative, chronic, inflammatory, and arthritic features. Psoriasis patients have been linked to an increased risk of cancer, though the underlying genetics remain unknown. Since our prior research indicated that BUB1B contributes to the development of psoriasis, we designed and carried out this investigation using bioinformatics analysis. Using the TCGA database, we investigated the oncogenic function of BUB1B in 33 tumor types. To sum up, our work sheds light on BUB1B's function in pan-cancer from various perspectives, including its pertinent signaling pathways, mutation locations, and connection to immune cell infiltration. BUB1B was shown to have a non-negligible role in pan-cancer, which is connected to immunology, cancer stemness, and genetic alterations in a variety of cancer types. BUB1B is highly expressed in a variety of cancers and may serve as a prognostic marker. This study is anticipated to offer molecular details on the elevated cancer risk that psoriasis sufferers experience.<\/jats:p>","DOI":"10.1038\/s41598-023-33174-3","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T12:03:24Z","timestamp":1681387404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pan-cancer investigation of psoriasis-related BUB1B gene: genetical alteration and oncogenic immunology"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiaobin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"33174_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"W-H Boehncke","year":"2015","unstructured":"Boehncke, W.-H. & Sch\u00f6n, M. P. Psoriasis. Lancet 386, 983\u2013994 (2015).","journal-title":"Lancet"},{"key":"33174_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ajd.12889","volume":"60","author":"M Rademaker","year":"2019","unstructured":"Rademaker, M. et al. Psoriasis and cancer. An Australian\/New Zealand narrative. Australas J. Dermatol. 60, 12\u201318 (2019).","journal-title":"Australas J. Dermatol."},{"key":"33174_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/1744666X.2020.1754194","volume":"16","author":"ND Loft","year":"2020","unstructured":"Loft, N. D., Vaengebjerg, S. & Skov, L. Cancer risk in patients with psoriasis: Should we be paying more attention?. Expert Rev. Clin. Immunol. 16, 479\u2013492 (2020).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"33174_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-0716-1839-4_17","volume":"2401","author":"G Agapito","year":"2022","unstructured":"Agapito, G. & Arbitrio, M. Microarray data analysis protocol. Methods Mol. Biol. 2401, 263\u2013271 (2022).","journal-title":"Methods Mol. Biol."},{"key":"33174_CR5","doi-asserted-by":"publisher","first-page":"14914","DOI":"10.1038\/s41598-022-19244-y","volume":"12","author":"B Ferolito","year":"2022","unstructured":"Ferolito, B. et al. Visualizing novel connections and genetic similarities across diseases using a network-medicine based approach. Sci. Rep. 12, 14914 (2022).","journal-title":"Sci. Rep."},{"key":"33174_CR6","doi-asserted-by":"publisher","first-page":"667690","DOI":"10.3389\/fimmu.2021.667690","volume":"12","author":"W Su","year":"2021","unstructured":"Su, W. et al. Exploring the pathogenesis of psoriasis complicated with atherosclerosis via microarray data analysis. Front. Immunol. 12, 667690 (2021).","journal-title":"Front. Immunol."},{"key":"33174_CR7","doi-asserted-by":"publisher","first-page":"606065","DOI":"10.3389\/fgene.2021.606065","volume":"12","author":"W Su","year":"2021","unstructured":"Su, W., Wei, Y., Huang, B. & Ji, J. Identification of hub genes and immune infiltration in psoriasis by bioinformatics method. Front. Genet. 12, 606065 (2021).","journal-title":"Front. Genet."},{"key":"33174_CR8","first-page":"93","volume":"45","author":"X Wang","year":"2020","unstructured":"Wang, X., Liu, X., Liu, N. & Chen, H. Prediction of crucial epigenetically-associated, differentially expressed genes by integrated bioinformatics analysis and the identification of S100A9 as a novel biomarker in psoriasis. Int. J. Mol. Med. 45, 93\u2013102 (2020).","journal-title":"Int. J. Mol. Med."},{"key":"33174_CR9","doi-asserted-by":"publisher","first-page":"14653","DOI":"10.1038\/s41598-022-19135-2","volume":"12","author":"X Li","year":"2022","unstructured":"Li, X., Tao, X. & Ding, X. An integrative analysis to reveal that CLEC2B and ferroptosis may bridge the gap between psoriatic arthritis and cancer development. Sci. Rep. 12, 14653 (2022).","journal-title":"Sci. Rep."},{"key":"33174_CR10","doi-asserted-by":"publisher","first-page":"662528","DOI":"10.3389\/fimmu.2021.662528","volume":"12","author":"S Adil","year":"2021","unstructured":"Adil, S. et al. A computational systems analyses to identify biomarkers and mechanistic link in psoriasis and cutaneous squamous cell carcinoma. Front. Immunol. 12, 662528 (2021).","journal-title":"Front. Immunol."},{"key":"33174_CR11","doi-asserted-by":"publisher","first-page":"3261300","DOI":"10.1155\/2022\/3261300","volume":"2022","author":"X Ding","year":"2022","unstructured":"Ding, X. et al. Pan-cancer analysis of BUB1B\/hsa-miR-130a-3p axis and identification of circulating hsa-miR-130a-3p as a potential biomarker for cancer risk assessment. Evid. Based Complement. Alternat. Med. 2022, 3261300 (2022).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"33174_CR12","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/nar\/gkm239","volume":"35","author":"E Myslinski","year":"2007","unstructured":"Myslinski, E., G\u00e9rard, M.-A., Krol, A. & Carbon, P. Transcription of the human cell cycle regulated BUB1B gene requires hStaf\/ZNF143. Nucleic Acids Res. 35, 3453\u20133464 (2007).","journal-title":"Nucleic Acids Res."},{"key":"33174_CR13","doi-asserted-by":"publisher","first-page":"12395","DOI":"10.18632\/aging.202944","volume":"13","author":"Z Long","year":"2021","unstructured":"Long, Z. et al. Expression and prognosis analyses of BUB1, BUB1B and BUB3 in human sarcoma. Aging (Albany NY) 13, 12395\u201312409 (2021).","journal-title":"Aging (Albany NY)"},{"key":"33174_CR14","doi-asserted-by":"publisher","first-page":"D1046","DOI":"10.1093\/nar\/gkaa1070","volume":"49","author":"J Navarro Gonzalez","year":"2021","unstructured":"Navarro Gonzalez, J. et al. The UCSC Genome Browser database: 2021 update. Nucleic Acids Res. 49, D1046\u2013D1057 (2021).","journal-title":"Nucleic Acids Res."},{"key":"33174_CR15","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson, E. K., Zhang, D., Reynolds, R. H., Garcia-Ruiz, S. & Ryten, M. ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics 38, 3844\u20133846 (2022).","journal-title":"Bioinformatics"},{"key":"33174_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899\u2013905 (2010).","journal-title":"Nature"},{"key":"33174_CR17","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: Efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"33174_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"33174_CR19","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77, e108\u2013e110 (2017).","journal-title":"Cancer Res."},{"key":"33174_CR20","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng, D. et al. IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front. Immunol. 12, 687975 (2021).","journal-title":"Front. Immunol."},{"key":"33174_CR21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812-830.e14 (2018).","journal-title":"Immunity"},{"key":"33174_CR22","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"33174_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173, 338-354.e15 (2018).","journal-title":"Cell"},{"key":"33174_CR24","first-page":"5058313","volume":"2019","author":"P Yu","year":"2019","unstructured":"Yu, P. et al. Transcriptome analysis of hypertrophic heart tissues from murine transverse aortic constriction and human aortic stenosis reveals key genes and transcription factors involved in cardiac remodeling induced by mechanical stress. Dis. Mark. 2019, 5058313 (2019).","journal-title":"Dis. Mark."},{"key":"33174_CR25","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013W560 (2019).","journal-title":"Nucleic Acids Res."},{"key":"33174_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2105-10-161","volume":"10","author":"W Luo","year":"2009","unstructured":"Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. & Woolf, P. J. GAGE: Generally applicable gene set enrichment for pathway analysis. BMC Bioinform. 10, 161 (2009).","journal-title":"BMC Bioinform."},{"key":"33174_CR27","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545\u2013D551 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"Suppl 3","key":"33174_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jdv.12165","volume":"27","author":"C Pouplard","year":"2013","unstructured":"Pouplard, C. et al. Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies. J. Eur. Acad. Dermatol. Venereol. 27(Suppl 3), 36\u201346 (2013).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"33174_CR29","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/bjd.21016","volume":"186","author":"ST S\u00f8rensen","year":"2022","unstructured":"S\u00f8rensen, S. T., Nagy, D., Lindahl, L. M., Farkas, D. K. & Troelsen, F. S. Risk of cancer in patients with psoriasis and venous thromboembolism: A Danish population-based cohort study 1996\u20132018. Br. J. Dermatol. 186, 1049\u20131050 (2022).","journal-title":"Br. J. Dermatol."},{"key":"33174_CR30","first-page":"D908","volume":"48","author":"V Neveu","year":"2020","unstructured":"Neveu, V., Nicolas, G., Salek, R. M., Wishart, D. S. & Scalbert, A. Exposome-Explorer 2.0: An update incorporating candidate dietary biomarkers and dietary associations with cancer risk. Nucleic Acids Res. 48, D908\u2013D912 (2020).","journal-title":"Nucleic Acids Res."},{"key":"33174_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/annonc\/mdw307","volume":"27","author":"S Michiels","year":"2016","unstructured":"Michiels, S., Tern\u00e8s, N. & Rotolo, F. Statistical controversies in clinical research: Prognostic gene signatures are not (yet) useful in clinical practice. Ann. Oncol. 27, 1\u20139 (2016).","journal-title":"Ann. Oncol."},{"key":"33174_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.molmed.2015.04.003","volume":"21","author":"M Kapanidou","year":"2015","unstructured":"Kapanidou, M., Lee, S. & Bolanos-Garcia, V. M. BubR1 kinase: Protection against aneuploidy and premature aging. Trends Mol. Med. 21, 364\u2013372 (2015).","journal-title":"Trends Mol. Med."},{"key":"33174_CR33","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1002\/cam4.3411","volume":"9","author":"J Qiu","year":"2020","unstructured":"Qiu, J. et al. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway. Cancer Med. 9, 8159\u20138172 (2020).","journal-title":"Cancer Med."},{"key":"33174_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41419-020-03234-x","volume":"12","author":"CY Jiao","year":"2021","unstructured":"Jiao, C. Y. et al. BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK\/c-Jun pathways. Cell Death Dis. 12, 63 (2021).","journal-title":"Cell Death Dis."},{"key":"33174_CR35","first-page":"2211","volume":"9","author":"X Fu","year":"2016","unstructured":"Fu, X. et al. Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer. Onco Targets Ther. 9, 2211\u20132220 (2016).","journal-title":"Onco Targets Ther."},{"key":"33174_CR36","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3389\/fonc.2019.01220","volume":"9","author":"AI Abd El Maksoud","year":"2019","unstructured":"Abd El Maksoud, A. I. et al. Selective regulation of B-Raf dependent K-Ras\/mitogen-activated protein by natural occurring multi-kinase inhibitors in cancer cells. Front. Oncol. 9, 1220 (2019).","journal-title":"Front. Oncol."},{"key":"33174_CR37","doi-asserted-by":"publisher","first-page":"10641","DOI":"10.1038\/s41598-022-13835-5","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer. Sci. Rep. 12, 10641 (2022).","journal-title":"Sci. Rep."},{"key":"33174_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1101\/gr.140301.112","volume":"23","author":"T-M Kim","year":"2013","unstructured":"Kim, T.-M. et al. Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes. Genome Res. 23, 217\u2013227 (2013).","journal-title":"Genome Res."},{"key":"33174_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28, 445\u2013489 (2010).","journal-title":"Annu. Rev. Immunol."},{"key":"33174_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1099\/jmm.0.003939-0","volume":"58","author":"S Jain","year":"2009","unstructured":"Jain, S., Kaur, I. R., Das, S., Bhattacharya, S. N. & Singh, A. T helper 1 to T helper 2 shift in cytokine expression: An autoregulatory process in superantigen-associated psoriasis progression?. J. Med. Microbiol. 58, 180\u2013184 (2009).","journal-title":"J. Med. Microbiol."},{"key":"33174_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","volume":"133","author":"DA Martin","year":"2013","unstructured":"Martin, D. A. et al. The emerging role of interleukin-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J. Invest. Dermatol. 133, 17\u201326 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"33174_CR42","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/jid.2009.319","volume":"130","author":"JT Elder","year":"2010","unstructured":"Elder, J. T. et al. Molecular dissection of psoriasis: Integrating genetics and biology. J. Invest. Dermatol. 130, 1213\u20131226 (2010).","journal-title":"J. Invest. Dermatol."},{"key":"33174_CR43","first-page":"2003376","volume":"8","author":"L Jia","year":"2021","unstructured":"Jia, L., Wang, Y. & Wang, C. circFAT1 promotes cancer stemness and immune evasion by promoting STAT3 activation. Adv. Sci. (Weinh.) 8, 2003376 (2021).","journal-title":"Adv. Sci. (Weinh.)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33174-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T13:22:02Z","timestamp":1681392122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33174-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33174"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33174-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"1 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6058"}}